Connecting you to content on EBSCOhost

Works matching IS 02724391 AND DT 2006 AND VI 67 AND IP 8

Results: 6

1

New generation angiotensin II type 1 receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-γ.

Published in:

Drug Development Research, 2006, v. 67, n. 8, p. 687, doi. 10.1002/ddr.20142

By:

Pershadsingh, Harrihar A.

Publication type:

Article

2

Stearoyl-CoA desaturase: a new therapeutic target of liver steatosis.

Published in:

Drug Development Research, 2006, v. 67, n. 8, p. 643, doi. 10.1002/ddr.20139

By:

Dobrzyn, Pawel;
Dobrzyn, Agnieszka

Publication type:

Article

3

Adiponectin as a therapeutic target for obesity-related metabolic and cardiovascular disorders.

Published in:

Drug Development Research, 2006, v. 67, n. 8, p. 677, doi. 10.1002/ddr.20141

By:

Wang, Yu;
Lam, Karen S.L.;
Xu, Aimin

Publication type:

Article

4

'The next big thing' in diabetes: clinical progress on DPP-IV inhibitors.

Published in:

Drug Development Research, 2006, v. 67, n. 8, p. 627, doi. 10.1002/ddr.20138

By:

von Geldern, Thomas W.;
Trevillyan, James M.

Publication type:

Article

5

Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders.

Published in:

Drug Development Research, 2006, v. 67, n. 8, p. 651, doi. 10.1002/ddr.20140

By:

Malmlöf, Kjell;
Hohlweg, Rolf;
Rimvall, Karin

Publication type:

Article

6

Exenatide effects on glucose metabolism and metabolic disorders common to overweight and obese patients with type 2 diabetes.

Published in:

Drug Development Research, 2006, v. 67, n. 8, p. 666, doi. 10.1002/ddr.20115

By:

Webb, David M.;
Wintle, Matthew;
Malone, James K.

Publication type:

Article